In pancreatic beta cells, GLP-1 receptor engagement boosts glucose catabolism and insulin secretion through the mTOR-dependent HIF-1 pathway, facilitating glycolysis and more robust insulin release
A patient losing 15-20% body weight may require dose reduction to avoid iatrogenic hyperthyroidism
Related Reading Semaglutide Tablets For Weight Loss Semaglutide Genetics Weight Management Weight Management Semaglutide Tcf7L2 Rs7903146 Weight Management Semaglutide Pparg Rs1801282 Pricing and availability current as of June 2026
Methods Animal surgery and post-surgery procedures All animal studies were conducted in compliance with EU directives for animal experimentation and were approved by the Ethical Committee of Paris North and The French Minister of Higher Education, Research and Innovation (MESRI APAFIS #8290)
We treated cells with both iHAP1 [16], a PP2A agonist, and LB-100 [17], an inhibitor of PP2A, and showed that iHAP1 mediated the activation of PP2A mitigated hypoxia-induced neuronal death (Supplemental Fig
Slower Titration Often Makes Sense GI side effects like nausea, vomiting, and diarrhea are the most common reason patients reduce their dose or discontinue GLP-1 therapy